Terrapin Asset Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Terrapin Asset Management’s Portfolio IBER.U Stock Details IBER.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,510	Closed	-$186K	–	223
2022 Q4	$186K	Buy	+18,510	New	+$185K	0.19%	131

Terrapin Asset Management's IBER.U Position: Q1 2023 in Review

Terrapin Asset Management sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q1 2023, closing a stake of 18,510 shares — an estimated $186K sold.

Terrapin Asset Management first reported a position in IBER.U in Q4 2022 and held it in 1 quarter. The position peaked at $186K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER.U as of Q1 2023.

Terrapin Asset Management reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q1 2023 after selling out during the quarter.
Terrapin Asset Management sold 18,510 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q1 2023, an estimated $186K.
Terrapin Asset Management first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q4 2022 and held it in 1 quarter.
Terrapin Asset Management's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $186K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q1 2023.

Based on Terrapin Asset Management's 13F filing for Q1 2023, filed 12 May 2023.